Haemonetics Sets Date for Investor Meeting

Monday, May 19, 2008 General News J E 4
BRAINTREE, Mass., May 19 Haemonetics Corporationannounced today that it will host an investor meeting on Thursday, May 29th atthe New York Stock Exchange.

The meeting is scheduled from 10 am - 1 pm, and is open to analysts,shareholders, and others in the investment community. Attendees must registerno later than May 21st. For more information, please contact Denise McEvilyat (781) 356-9457 or

Other audiences may participate in the meeting via live webcast.Information on the webcast will be posted on the Company's website the daybefore the event.

Haemonetics (NYSE: HAE) is a global healthcare company dedicated toproviding innovative blood management solutions for our customers. Together,our devices and consumables, information technology platforms, and consultingservices deliver a suite of business solutions to help our customers improveclinical outcomes and reduce the cost of healthcare for blood collectors,hospitals, and patients around the world. Our technologies address importantmedical markets: blood and plasma component collection, the surgical suite,and hospital transfusion services. To learn more about Haemonetics, visit ourweb site at agenda for the meeting includes: -- Fiscal 2009 annual operating plan review -- Fiscal 2009 transformational restructuring -- Blood Management Solutions strategy -- R&D review

SOURCE Haemonetics Corporation


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Increased Competition, Generic Erosion and Cost Co...
LifeMasters Expands Disease Management Offerings t...